Upcoming IPO: Agilus Diagnostics Refiled DRHP with SEBI to Launch IPO

Agilus Diagnostics Limited has refiled the draft red herring prospectus (DRHP) with the market regulator, the Securities and Exchange Board of India (SEBI), to float an IPO. Previously, the company filed the DRHP in month of September 2023.

Agilus Diagnostics IPO Details

Agilus Diagnostics IPO is entirely an offer for sale of 1,42,33,964 equity shares. The selling shareholders include International Finance Corporation, NYLIM, Jacob Ballas India Fund III LLC and Resurgence PE Investments Limited. The shares of Agilus Diagnostics will be listed on the BSE and the NSE.

Use of IPO Proceeds

The Selling Shareholders will be entitled to the entire proceeds of the Offer after deducting the Offer expenses and relevant taxes thereon. Agilus Diagnostics will not receive any proceeds from the Offer.

Also Read: How to Apply for an IPO?

About Agilus Diagnostics Limited

Established in 1995, Agilus Diagnostics Limited is the largest diagnostics service provider in India by the number of laboratories and ranks second in terms of revenue from operations as of FY23. The company offers a wide range of services, including routine and specialised diagnostic tests, wellness and preventive health packages, hospital laboratory management, and clinical trial testing. As of March 31, 2023, Agilus has developed a vast diagnostics network across 25 states and 5 union territories, covering more than 1,000 towns and cities and over 532 districts in India. This network operates on a ‘hub-and-spoke’ model.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.